Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Authors: Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour, John M. Bennett, John C. Byrd, Jay T. Backstrom, Linda Zimmerman, David R. McKenzie, C.L. Beach, Lewis R. Silverman - The Lancet 2009 cited by 2,640